Status:
COMPLETED
Efficacy and Safety of Pramipexole Compared to Placebo in the Treatment of Restless Legs Syndrome (RLS)
Lead Sponsor:
Boehringer Ingelheim
Conditions:
Restless Legs Syndrome
Eligibility:
All Genders
18-80 years
Phase:
PHASE3
Brief Summary
A 12 week clinical trial was conducted in the United States in order to compare pramipexole (Mirapex®) versus placebo for the ability to reduce the symptoms of restless legs syndrome in adult subjects...
Eligibility Criteria
Inclusion
Exclusion
Key Trial Info
Start Date :
April 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2005
Estimated Enrollment :
345 Patients enrolled
Trial Details
Trial ID
NCT00133198
Start Date
April 1 2004
End Date
February 1 2005
Last Update
November 8 2013
Active Locations (44)
Enter a location and click search to find clinical trials sorted by distance.
1
Pivotal Research Centers
Peoria, Arizona, United States, 85381
2
Mayo Clinic - Scottsdale
Scottsdale, Arizona, United States, 85259
3
Boehringer Ingelheim Investigational Site
Fountain Valley, California, United States, 92708
4
HealthQuest Clinical Trials Research
San Diego, California, United States, 92123